Clinical chronic pancreatitis
- PMID: 27341355
- PMCID: PMC5658269
- DOI: 10.1097/MOG.0000000000000293
Clinical chronic pancreatitis
Abstract
Purpose of review: To summarize observations in clinical chronic pancreatitis in the past year.
Recent findings: A predisposing genetic mutation was identified in 67% of cases of pediatric chronic pancreatitis. A novel susceptibility gene involving a hybrid allele is associated with idiopathic chronic pancreatitis. ABO blood type B and FUT2 nonsecretor status is associated with asymptomatic hyperlipasemia and chronic pancreatitis. Alcohol consumption impairs cystic fibrosis transmembrane conductance regulator (CFTR) activity leading to decreased bicarbonate secretion and patients with susceptible CFTR mutations can develop clinical pancreatitis. Computed tomography imaging findings in chronic pancreatitis correlate poorly with pain patterns. Endoscopic ultrasound features correlate poorly with fibrosis. Circulating epithelial cells are present in chronic pancreatitis patients but not healthy volunteers. Surgery is superior to endoscopic treatment in providing durable pain relief (>5 years). Repetitive pancreatic duct stent placements and chronic narcotic use are preoperative predictors of poor outcome after total pancreatectomy with islet cell auto transplantation.
Summary: Novel genetic mutations for idiopathic chronic pancreatitis are being identified. Alcohol impairs CFTR activity and may explain a mechanism for pancreatitis. Current imaging modalities correlate poorly with clinical pain presentation and fibrosis in chronic pancreatitis. Novel imaging modalities are needed. As total pancreatectomy with islet cell auto transplantation grows, rigorous outcomes analysis is needed to drive patient selection.
Conflict of interest statement
References
-
- Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011;106(12):2192–9. - PubMed
-
- Schwarzenberg SJ, Bellin M, Husain SZ, Ahuja M, Barth B, Davis H, et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. The Journal of pediatrics. 2015;166(4):890–6.e1. The International Study Group of Pediatric Pancreatitis: In Search for a Cure (INSPPIRE) consortium described a cohort of 76 pediatric CP cases. In 67% of cases, a predisposing genetic mutation was identified. The most common imaging abnormalities included ductal irregularities and atrophy with calcifications being uncommon. The high burden of disease was evident as 70% missed 1 day of school in the past month with a median 3 ER visits and 2 hospitalizations in the last year. - PMC - PubMed
-
- Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature genetics. 1996;14(2):141–5. - PubMed
-
- Fjeld K, Weiss FU, Lasher D, Rosendahl J, Chen JM, Johansson BB, et al. A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis. Nature genetics. 2015;47(5):518–22. A hybrid genetic mutation (CEL-HYB) combined of carboxyl ester lipase (CEL), which is a lipase that is activated by bile salts in the duodenum, and its neighbor pseudogene CELP, shows reduced lipolytic activity impaired secretion and increased intracellular accumulation and induced autophagy. It is found in a higher proportion of non-alcoholic CP cases (14.1% vs. 1.0%) in a discovery series and 3.7% versus 0.7% (controls) in a replication study. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous